🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

$HIMS CEO ANDREW DUDUM “Tomorrow’s a small glimpse into the future of what we’re building. What I believe is one aspect of the future of healthcare.” I don’t know about you but no one is sleeping tonight inside Hims House Feels like Christmas Eve 🍏

OVERHEARD IN $HIMS HOUSE 🔥 "This is masterful brand building and a preview of how their platform will be built on products like this, focusing on manufacturing process and design and excellence in attention to every tiny detail. It’s like when you date a person and her or his

$HIMS - MULTIPLE FIRMS PROJECT THE GUMMY SUPPLEMENT MARKET TO BE A $40-50 BILLION MARKET IN THE NEXT FEW YEARS 🔥 SOURCES: Fortune Business Insights, Straits Research, DataM Intelligence, MarketsandMarkets

$HIMS SHORTS HAVE TWO BIG PROBLEMS 1. The worst is already behind us. Credit card data suggests the bottom came the week ending May 11. April/May was the usual seasonal dip — and June is already rebounding. 2. The bottom wasn't even that bad. Many were bracing for a collapse

Here’s what’s fishy to me about $HIMS and $NVO 1-how was compounding GLP-1s okay when there was a shortage, but now is suddenly “endangering patient safety”? 2- Why not also end the partnership with players like Noom, Ro, and others who continue to compound GLP-1s? To me,

$HIMS increased its customer base by +35% since its $NVO partnership was announced when it bought ZAVA last month Meaning, they used the $NVO partnership deal bounce to raise $1 Billion in Cash and increased their company by +35% in 1 month. With the $NVO deal gone now, they

$HIMS FORMER VP OF PHARMACY: WE USE SAME CHINESE SUPPLIER AS NOVO NORDISK Novo Nordisk's press release this morning says it is "deeply concerned" about knock-off drugs made with foreign illicit APIs and is taking action to protect U.S. patients. BUT according to an expert call

$HIMS Who are the DARING SOULS to buy this massive -32% dip? Raise your mf’in hands. 🙋🏽🙋‍♀️🙋🏻‍♂️

Why is Novo trying to sabotage $hims? I'm guessing they feel threatened

Big pharma accusing $HIMS of being deceptive is the most hypocritical statement of the year. Buy the dip.

$NVO Wegovy is still available on the $HIMS website at the "long-term-collaboration" discounted price of $549/month. In other words, the $NVO press release was an ambush.

I bought 5,000 more $HIMS today 😊

If big pharma is bullying $HIMS it just means they feel desperate and threatened. If HIMS wasn’t making waves in the medical industry there would be no drama. I’m more bullish than ever on HIMS. And it is trading VERY CHEAPLY now. Happy Monday everybody!

If you are selling $HIMS today, it means that you believe that $NVO are telling the truth and $HIMS have committed fraud. I’m buying $HIMS today… you now know my opinion 🤝🏼

We are disappointed to see Novo Nordisk management misleading the public. In recent weeks, Novo Nordisk’s commercial team increasingly pressured us to control clinical standards and steer patients to Wegovy regardless of whether it was clinically best for patients. We refuse to

🚨 $HIMS CEO ANDREW DUDUM RESPONDS TO NOVO NORDISK'S DECISION TO TERMINATE LONG-TERM COLLABORATION

Response from $HIMS CEO Always trusted the management of this company.

Big pharma strong arming an up and coming disruptive company trying to change a trillion dollar industry? Who would have thought? I choose to side with $HIMS and andrewdudum here.

JUST IN: $HIMS' Founder and CEO has responded to Novo Nordisk’s accusations. 👀 As expected, the company will continue to push its personalized GLP-1 offerings. Yikes.

I trust andrewdudum here. Sorry Team Novo Nordisk . $HIMS, the largest telemedicine player, is taking market share from $NVO and $LLY. $NVO has struggled in the past 2 years and likely resents $HIMS. Based on the $HIMS earning calls before, CEO mentioned that $HIMS's compounded